1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of european experience and conclusions

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 2130-2135

  Philip, T ^a   Ladenstein, R ^a,b   Lasset, C ^a   Hartmann, O ^c   Zucker, J M ^d   Pinkerton, R ^e   Pearson, A D J ^f   Klingebiel, T ^g   Garaventa, A ^h   Kremens, B ⁱ   Bernard, J L ^j   Rosti, G ^k   Chauvin, F ^a  

^a CENTRE LÉON BÉRARD   (France)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d INSTITUT CURIE   (France)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

^f ROYAL VICTORIA INFIRMARY   (United Kingdom)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^h G GASLINI INSTITUTE   (Italy)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j TIMONE HOSPITAL   (France)

^k Ospedale Civile   (Italy)

more..

Author keywords

EBMT; Myeloablative therapy; Neuroblastoma

Indexed keywords

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONFERENCE PAPER; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0031431549     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00324-9     Document Type: Conference Paper

References (19)

1. Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant. 8:1991;197-201.
2. Rosti G, Philip T, Chauvin F, et al. European Group for Blood and Marrow Transplantation (EBMT) registry in solid tumors: 12 years of experience. Bone Marrow Transplant 1996, 17 (Suppl. 1p), S106, abstract 469.
3. Ladenstein R, Lasset C, Philip T. For the European Bone Marrow Transplant Group. Treatment duration before bone marrow transplantation in stage 4 neuroblastoma. Lancet (Letter) 1992, 340, 916-917.
4. Garaventa A, Ladenstein R, Chauvin F, et al. High dose chemotherapy with autologous bone marrow rescue in advanced stage 4 neuroblastoma. Eur J Cancer 1993, 29A(4), 487-491.
5. Ladenstein R, Hartmann O, Pinkerton C. R. The role of megatherapy with autologous bone marrow rescue in solid tumours of childhood. Ann Oncol. 4:(Suppl. 1):1993;45-58.
6. Ladenstein R, Lasset C, Hartmann O, Garaventa A, Philip T. For the European Bone Marrow Transplant Group. High dose consolidation chemotherapy in infants with stage 4 neuroblastoma. Eur J Cancer (Letter) 1993, 29A, 11, 1632.
7. Ladenstein R, Lasset C, Hartmann O, et al. Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation. J Clin Oncol 1993, 11, 2330-2341.
8. Ladenstein R, Lasset C, Hartmann O, et al. Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994, 14, 37-46.
9. Philip T. High dose therapy and ABMT rescue in lymphoma and solid tumours. Eur J Cancer. 31:1995;808-809.
10. Philip T. Chimiothérapie massive suivie d'autogreffe de moelle en oncologie pédiatrique: pour ou contre? Bull Cancer. 82:1995;3-5.
11. Hartmann O, Valteau-Couanet D, Benhamou E. Chimiothérapie à hautes doses suivie d'autogreffe de moelle dans les tumeurs solides de l'enfant: les arguments pour. Bull Cancer. 82:1995;36-41.
12. Pinkerton R. Chimiothérapie massive suivie d'autogreffe de moelle en oncologie pédiatrique: les arguments contre. Bull Cancer. 82:1995;42-45.
13. Dini G, Garaventa A, Chauvin F, et al. On behalf of the EBMT Group. Bone marrow transplantation for neuroblastoma: a review of 509 cases. In Bernasconi C, Burgio GR, eds. Bone Marrow Transplantation in Children and Adults. New Trends in the Therapy of Leukemia and Lymphoma, December 1989, No. 4, 42-46.
14. Pinkerton CR, Hartman O, Dini G, Philip T. High dose chemo-radiotherapy with bone marrow rescue in stage 4 neuroblastoma: EBMT survey 1988. In Dicke KA, ed. 4th International Conference on ABMT, Houston, Texas, 1990, 543-549.
15. Ladenstein R, Philip T. Innovative therapies in pediatric solid tumors: megatherapy and immunotherapy. In Pinkerton R, Plowman, eds. Paediatric Oncology: Clinical Practice and Controversies. London, Chapman & Hall, 1992, 460-494.
16. Philip T, Ladenstein R, Linkesch W. Recent aspects on the role of megatherapy followed by bone marrow rescue in high-risk neuroblastoma, malignant brain gliomas and poor prognosis Ewing sarcoma. A summary of the solid tumor session II at the 19th Annual Meeting of the EBMT (Garmisch-Partenkirchen, Germany, January 1993). Bone Marrow Transplant. 12:(Suppl. 4):1993;S82.
17. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. N Engl J Med 1985, 313, 1111-1116.
18. Nickerson H. J., Nesbit M. E., Grosfeld J. L., et al. Comparison of stage 4 and 4s neuroblastoma in the first year of life. Med Pediatr Oncol. 13:1985;261-268.
19. Paul S. R., Tarbell N. J., Korf B, et al. Stage 4 neuroblastoma in infants: long-term survival. Cancer. 67:1991;1493-1497.